CN Patent
CN102805729A — 一种长春氟宁脂质体制剂及其制备方法
Assigned to Qilu Pharmaceutical Co Ltd · Expires 2012-12-05 · 13y expired
What this patent protects
本发明涉及一种长春氟宁的脂质体制剂及其制备方法,主要包含长春氟宁或其药学上可接受的盐、磷脂、胆固醇和聚乙二醇化的二硬脂酰磷脂酰乙醇胺,可以制备成注射液或冻干制剂。本制备方法工艺简单、易于操作,适合工业化生产,采用本发明方法所制备的长春氟宁长循环脂质体包封率高、稳定性好。
USPTO Abstract
本发明涉及一种长春氟宁的脂质体制剂及其制备方法,主要包含长春氟宁或其药学上可接受的盐、磷脂、胆固醇和聚乙二醇化的二硬脂酰磷脂酰乙醇胺,可以制备成注射液或冻干制剂。本制备方法工艺简单、易于操作,适合工业化生产,采用本发明方法所制备的长春氟宁长循环脂质体包封率高、稳定性好。
Drugs covered by this patent
- Camptosar (Irinotecan Hydrochloride) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.